I am a hematologist who specializes in the treatment of patients with plasma cell disorders, such as multiple myeloma and amyloidosis. I completed my residency and hematology/medical oncology fellowship here at The Ohio State University, where I became passionate about how the immune system affects myeloma growth, response to therapy and risk of infections. As a cancer-treating physician, my goal is to tailor therapies, reduce toxicities and improve the quality of life of my patients. At the OSUCCC – James, we work as a multidisciplinary team to identify and test innovative therapeutic approaches in the lab that can be rapidly applied to patients in the clinic. This derives from the perfect interactions between bench research, drug development efforts and clinical care. As a member of the Translational Therapeutics Program at the OSUCCC – James, my laboratory research focuses on the development of translational therapeutics for patients with multiple myeloma. My objective is to integrate concepts of myeloma biology, genomics and immunotherapy to improve patient outcomes by personalized therapeutic approaches. Currently, I am developing novel therapeutic approaches to benefit patients at high risk of poor outcomes, using both 2D and 3D models to study the interactions between myeloma cells and the tumor microenvironment. My work has been patented, presented at major conferences and published in numerous peer-reviewed journals, including Nature Medicine, Cancer Discovery, Blood Cancer Journal, Leukemia, Blood, Leukemia & Lymphoma, and Amyloid. I am a member of national and international scientific organizations, such as the American Society of Hematology, the European Hematology Association and the American Society of Clinical Oncology. I also serve as a reviewer for several scientific journals. My research has been supported by the Multiple Myeloma Research Foundation, the International Myeloma Society, the Pelotonia Foundation, the Pardee Foundation, and the National Cancer Institute. In addition to my clinical and research work, I am an assistant professor in the Division of Hematology at The Ohio State University, where I help to train the next generation of cancer physicians and researchers. I love working at the OSUCCC – James because it provides me various avenues to contribute to our mission of creating a cancer-free world. Everybody is dedicated to providing optimal care for our patients and progressing our research with laboratory science and clinical trials.